Cyrus Soli Poonawalla

Pune, India

Cyrus Soli Poonawalla

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Serum Institute of India Private Limited. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cyrus Soli Poonawalla. Retrieved from https://idiyas.com/inventor/cyrus-soli-poonawalla

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Cyrus Soli Poonawalla: A Pioneer in Vaccine Development

Introduction

Cyrus Soli Poonawalla is a distinguished inventor based in Pune, Maharashtra, India, known for his significant contributions to the field of immunology. With a focus on enhancing vaccine stability, his innovative work has the potential to transform the way vaccines are developed and stored.

Latest Patents

Cyrus holds a patent for a "Stable vaccine compositions comprising inter alia live attenuated recombinant flavivirus and process for preparation thereof." This groundbreaking patent describes stable lyophilized immunogenic compositions that incorporate live attenuated recombinant flaviviruses, particularly dengue viruses. The unique formulation includes carbohydrates and amino acids, and is tailored for rapid freeze-drying processes that maintain the virus's viability, immunogenicity, and stability. Importantly, this composition does not contain preservatives, polymers, or surfactants, making it a safe option for vaccine preparation. The patent also outlines methods for the manufacturing of these stable lyophilized immunogenic compositions, reaffirming his commitment to advancing public health through innovative solutions.

Career Highlights

Cyrus Poonawalla is affiliated with the Serum Institute of India Private Limited, a leading biotechnology company renowned for its contributions to vaccine production. His work at the institute reflects a commitment to research and development in the arena of vaccine technology, with particular emphasis on ensuring that immunizations are both effective and safe for public use.

Collaborations

Throughout his career, Cyrus has collaborated with prominent scientists and researchers, including Rajeev Mhalasakant Dhere and Leena Ravindra Yeolekar. These collaborations have led to noteworthy advancements in vaccine formulation and production processes, underscoring the importance of teamwork in research and development.

Conclusion

Cyrus Soli Poonawalla’s contributions to the field of vaccine innovations highlight the critical role of inventors in shaping public health. His patented work on stable vaccine compositions marks a significant milestone in immunology, demonstrating how innovation can lead to safer and more effective vaccines. As the world continues to face health challenges, the impact of such inventions will undoubtedly play a vital role in the future of healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…